Form 10-Q · Quarterly report
IBM 10-Q, filed Oct 22, 2026
- Filed
- CIK
- 0000051143
- Accession no.
- 0000051143-26-000095
Summary
IBM reported third-quarter 2026 revenue of $17.1 billion, up 4.7% from a year earlier, with income from continuing operations of $2.2 billion, up 26.1%, and said software revenue grew 8.2% while consulting was flat. For the nine months ended September 30, 2026, revenue was $50.2 billion, up 4.9%.
Key points
- Third-quarter revenue was $17.1 billion, up 4.7% as reported and 5.6% adjusted for currency; software revenue rose 8.2%, infrastructure 4.2%, and consulting was flat.
- Income from continuing operations rose 26.1% to $2.2 billion; operating (non-GAAP) earnings were $2.8 billion, or $2.95 per diluted share versus $2.65 a year earlier.
- Diluted earnings per share from continuing operations were $2.31, up 25.5%, and the quarter's tax provision fell to $0.3 billion from $0.7 billion, which included a one-time non-cash charge from the enactment of H.R. 1.
- IBM generated $4.0 billion in cash from operations and $3.0 billion in free cash flow, and returned $1.6 billion to shareholders in dividends.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 Snapshot Organization of Information: The Management Discussion is designed to provide readers with an overview of the business and a narrative on our financial results and certain factors that may affect our future prospects from the perspective of management. Within the tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages presented are calculated from the underlying whole-dollar amounts. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.